Literature DB >> 19368628

Will non-invasive markers replace liver biopsy for diagnosing and staging fibrosis in non-alcoholic steatohepatitis?

Etsuko Hashimoto, Geoffrey C Farrell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19368628     DOI： 10.1111/j.1440-1746.2009.05806.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.029


× No keyword cloud information.
  7 in total

1.  Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan.

Authors:  Yoshio Sumida; Yuichiro Eguchi; Masafumi Ono
Journal:  World J Hepatol       Date:  2010-10-27

2.  Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study.

Authors:  Yuichiro Eguchi; Hideyuki Hyogo; Masafumi Ono; Toshihiko Mizuta; Naofumi Ono; Kazuma Fujimoto; Kazuaki Chayama; Toshiji Saibara
Journal:  J Gastroenterol       Date:  2012-02-11       Impact factor: 7.527

3.  Multicenter investigation of lifestyle-related diseases and visceral disorders in thalidomide embryopathy at around 50 years of age.

Authors:  Tomoko Shiga; Takuro Shimbo; Atsuto Yoshizawa
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-06-02

4.  The Clinical Difference in the Platelet Counts between Liver Cirrhosis with Nonalcoholic Fatty Liver Disease and Hepatitis C Virus.

Authors:  Yuichi Ikarashi; Kazuhisa Kodama; Makiko Taniai; Etsuko Hashimoto; Katsutoshi Tokushige
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

5.  Systematic analysis of the gene expression in the livers of nonalcoholic steatohepatitis: implications on potential biomarkers and molecular pathological mechanism.

Authors:  Yida Zhang; Susan S Baker; Robert D Baker; Ruixin Zhu; Lixin Zhu
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

6.  Serum metabolomic profile and potential biomarkers for severity of fibrosis in nonalcoholic fatty liver disease.

Authors:  Katsutoshi Tokushige; Etsuko Hashimoto; Kazuhisa Kodama; Maki Tobari; Noriko Matsushita; Tomomi Kogiso; Makiko Taniai; Nobuyuki Torii; Keiko Shiratori; Yasuhiro Nishizaki; Takushi Ohga; Yoshiaki Ohashi; Takaya Sato
Journal:  J Gastroenterol       Date:  2013-03-13       Impact factor: 7.527

Review 7.  Nonalcoholic fatty liver disease: Diagnostic biomarkers.

Authors:  Fatemeh Hadizadeh; Elham Faghihimani; Peyman Adibi
Journal:  World J Gastrointest Pathophysiol       Date:  2017-05-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.